Azra AI
Custom subscription model
Overview
Azra AI is a healthcare enterprise platform that utilizes proprietary artificial intelligence and machine learning software to analyze unstructured clinical data in real-time. The platform is designed to identify, connect, and manage patients across various clinical workflows, with a primary focus on oncology. It aims to operationalize underutilized data to optimize and orchestrate care and clinical trial pathways, ensuring patients receive immediate, coordinated care within a health system. Azra AI integrates with existing Electronic Health Record (EHR) systems, transforming stored clinical data into structured, accountable workflows. The company offers solutions for radiology, oncology, clinical research, cardiology, and emergency department discharge coordination. Additionally, Azra AI provides clinical advisory services, including strategic execution, clinical and non-clinical navigation, multidisciplinary meeting (MDM) / tumor board support, and cancer registry case finding.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered patient identification (pathology/radiology AI)
- Incidental findings detection
- Cancer registry automation (SmartPathu2122 / Flowu2122)
- Tumor board management (Compassu2122)
- Patient care coordination & navigation (Journeyu2122)
- Real-time data & analytics (Azra IQu2122)
- Seamless EHR integration
- Clinical trial matching and pre-screening
- Closed-loop patient management
- Compliance monitoring for screening follow-up
Use Cases
- Accelerating time to cancer treatment
- Automating cancer registry reporting (NAACCR compliance)
- Streamlining patient navigation
- Managing incidental findings follow-up
- Optimizing oncology service line performance
- Enhancing clinical research patient enrollment
What Physicians Need to Know
Evidence Base (guidelines, literature scope)
Azra AI's models are trained on extensive oncology-specific clinical data and continuously refined and validated against real-world outcomes. [14] They utilize natural language processing (NLP) to interpret pathology and radiology reports and classification models to determine primary site and stage. [14] The platform incorporates evidence-based risk calculators and guideline-aligned care pathways for various cancer types and incidental findings. [7, 14] For example, it applies ACG and AGA guidelines for pancreatic incidentalomas and automates Lung-RADS and BI-RADS scoring for pulmonary nodules and mammograms, respectively. [7, 19] The system also leverages multimodal data integration and agentic AI to transform fragmented clinical data into actionable intelligence across various solutions, including lung and breast cancer screening, incidental findings, and clinical trial matching. [3, 5, 6]
Clinical Validation Studies
Azra AI's platform has demonstrated significant improvements in clinical workflows and patient outcomes. A case study with HCA Healthcare showed that after implementing Azra AI, the time spent by navigators directly interacting with patients doubled, and the average speed to treatment decreased by seven days. [12] The technology reduced manual review of pathology reports from an estimated 11,963 hours to 822 hours, freeing up over 11,000 hours for clinicians to spend with patients. [12] The AI models boast a precision rate of up to 98% in identifying new cancer diagnoses and suspicious incidental findings from pathology and radiology reports. [16] In partnership with RevealDx, their technology for characterizing incidental lung nodules (RevealAI-Lung) has been validated on over 1,500 patients and is FDA-cleared. [6]
Alert Fatigue Management
While Azra AI's primary focus is on automating patient identification and care coordination rather than generating numerous alerts for physicians, its design inherently addresses alert fatigue by streamlining workflows and prioritizing high-risk cases. [7, 13, 16] The system automatically routes patients into the correct care pathway without manual intervention and provides prioritized worklists for care navigators, sorted by urgency and severity. [7, 13, 19] For multidisciplinary case reviews, it offers automated escalation for overdue or unacknowledged items, ensuring critical actions are not missed due to oversight. [13] The platform aims to reduce manual, repetitive processes, allowing care teams to focus on patient care rather than administrative tasks, which is a key strategy in mitigating alert fatigue. [16]
Override Rate Data
Specific override rate data for physician decisions within Azra AI is not explicitly provided in the available information. However, the platform is designed to keep clinicians in control with 'human-in-the-loop' review for care coordination. [7] The system emphasizes transparency, particularly in its clinical research platform, where every eligibility determination is traceable with precise document text citations. [11] This suggests a design that aims to build trust and provide clear rationale for AI-driven insights, which can indirectly influence override rates by increasing clinician confidence.
Drug Interaction Checking
The provided information does not indicate that Azra AI directly offers drug interaction checking as a core feature. Its primary focus is on oncology and radiology workflows, incidental findings, and care coordination. [2, 5, 7, 14, 16] AI-powered drug interaction checkers are a distinct category of clinical decision support tools that analyze complex multi-drug regimens and patient-specific factors to identify potential harmful interactions. [23, 24]
Differential Diagnosis Support
Azra AI's capabilities are centered on identifying and classifying specific conditions, particularly in oncology and incidental findings, rather than providing broad differential diagnosis support. [7, 14, 16] It excels at extracting and structuring clinical details like stage, grade, and tumor markers from reports, and applying classifications like Lung-RADS and Bosniak. [7, 14] While this supports accurate diagnosis, it's not a tool for generating a list of possible diagnoses based on symptoms.
Clinical Workflow Integration
Azra AI is designed for seamless, bidirectional integration with existing Electronic Health Record (EHR) systems like Epic and Cerner, as well as any HL7/FHIR-compatible system. [4, 7] It ingests HL7/FHIR messages directly from EHRs, radiology systems, and labs in real time. [7, 19] The platform transforms stored clinical data into structured, accountable workflows embedded within existing systems, acting as an enterprise patient management layer while the EHR remains the system of record. [4] It populates discrete EHR fields with risk scores, finding classifications, and stage data, and sends navigation activities back to the EHR in real time, eliminating double documentation. [7, 16] Chart updates in the EHR also surface back into Azra AI, ensuring both systems are synchronized. [7]
Decision Audit Trail
Azra AI maintains a comprehensive audit trail for compliance and accreditation reporting. [13] Every AI recommendation and clinician decision is timestamped and stored in both Azra AI and the integrated EHR systems. [7] For its clinical research platform, it offers full traceability to the source of every patient match, allowing researchers to view the original, de-identified EMR data for audit, verification, and data integrity. [3, 11] This ensures transparency and accountability throughout the decision-making process.
Physician Tip
Leverage Azra AI to offload the manual burden of identifying and tracking incidental findings and cancer diagnoses, allowing more time for direct patient interaction and complex clinical decision-making. Trust the AI's high precision in identifying critical cases, but utilize the transparent audit trail and human-in-the-loop review to understand the rationale and maintain clinical oversight. Integrate Azra AI deeply into your existing EHR workflows to avoid double documentation and ensure a unified view of patient care across the continuum, especially for oncology and incidental findings management. Utilize the platform's ability to streamline multidisciplinary case reviews and ensure timely follow-up on recommendations, improving care coordination and patient outcomes.
Azra AI offers robust, bidirectional integration with major EHR systems such as Epic and Cerner, as well as any HL7/FHIR-compatible system. [4, 7] This allows for real-time ingestion of pathology and radiology reports and clinical records, and seamless write-back of structured data, risk scores, and navigation activities into the EHR. [7, 14, 19] The platform also integrates with specific technologies like RevealAI-Lung for characterizing lung nodules and is partnering with 4DMedical for quantitative lung imaging analytics, expanding its capabilities in lung health. [6, 10, 15] These integrations aim to create a unified patient intelligence layer and orchestrate care across various service lines without disrupting existing systems. [3, 4, 5]
Details
| Category | Clinical Decision Support & Reference, EMR / EHR Systems, Oncology AI |
| Pricing |
Custom subscription model
|
| Deployment | Cloud, SaaS |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated Azra AI's partners have received FDA clearance for their integrated technologies. For example, 4DMedical's CT:VQ™ functional lung imaging solution is FDA-cleared and integrates with Azra AI for enhanced patient discovery and care coordination. Additionally, RevealDx's RevealAI-Lung technology, which characterizes incidental lung nodules, is FDA cleared and integrated into Azra AI's clinical workflows. |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pathology, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Azra AI
Press & Coverage
Azra AI (Press Release)
Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
Azra AI and 4DMedical announced a strategic partnership to integrate Azra AI's real-time patient identification and care coordination platform with 4DMedical's quantitative lung imaging analytics, aiming to enhance lung health management for health systems.
2026-08
Azra AI (Press Release)
Azra AI and Blackford Announce Strategic Partnership to Close the Gap Between Imaging AI and Enterprise Care Coordination
Azra AI and Blackford have formed a strategic partnership to connect Blackford's extensive AI imaging applications with Azra AI's care coordination platform, aiming to streamline the detection-to-treatment pathway for patients with complex diagnoses.
2026-08
Azra AI (Press Release)
AZRA AI Unveils Agentic AI Clinical Research Platform Built on Azra AI's Real-Time Care Orchestration Engine
Azra AI launched its Agentic AI Clinical Research Platform, which utilizes a Unified Patient Intelligence Layer to harmonize fragmented EMR data, thereby powering the entire clinical trial lifecycle and accelerating patient identification for trials.
2026-05
Azra AI (Press Release)
Azra AI Acquires Thynk Health to Close the Gap Between Imaging and Cancer Care
Azra AI announced the acquisition of Thynk Health, a leader in lung cancer screening and incidental findings management, to unite their platforms and improve imaging-driven care coordination for cancer patients.
2026-04
medtechrec News
4DMedical and Azra AI Partner to Advance Lung Care Pathways
4DMedical and Azra AI have partnered to integrate automated patient identification with advanced lung imaging, aiming to improve the detection and treatment of respiratory diseases and transform lung health management.
2026-08
MarketsandMarkets
AI in Oncology Market: Top 7 Companies in 2026
Azra AI is recognized as a top company in the AI in oncology market for 2026, noted for its AI platform that swiftly analyzes, identifies, and classifies cancer patients to enhance oncology care.
2026-02
ASCO Publications (Journal of Clinical Oncology)
Oncologist-Advanced Practice Provider Dyad: A Roadmap for Creating Synergy and Better Patient Care
This article discusses the role of artificial intelligence, including Azra AI, in enhancing the collaboration between oncologists and advanced practice providers to improve patient care by managing repetitive administrative functions.
2026-06
Signify Research
Medicare Payment for AI Triage and FDA Pressure on Vision Language Models
This article mentions the strategic partnership between Azra AI and Blackford, highlighting a shift in imaging AI value towards closing the loop between flagged findings and scheduled interventions, particularly in incidental finding management.
2026-09
Frequently Asked Questions
Azra AI overlays your EHR with bidirectional integration, transforming stored clinical data into structured workflows embedded within your existing systems. Your EHR remains the system of record, while Azra AI acts as an enterprise patient management layer. It populates discrete EHR fields and sends every navigation activity back into the patient chart automatically, ensuring real-time synchronization of new results, updated orders, and rescheduled appointments.
Azra AI offers solutions across various clinical areas including oncology, radiology, cardiology, and clinical research. It improves patient outcomes by identifying high-risk findings, such as incidental lung nodules or suspicious masses, and routing patients to the appropriate care pathways. This automation leads to faster time to treatment, increased patient retention, and more nurse-patient interaction time.
Azra AI prioritizes compliance with HIPAA regulations and safeguards sensitive patient information. It achieves this through dedicated, HIPAA-compliant cloud environments for each hospital system, preventing cross-tenant data leakage. Data anonymization protocols are also used during AI training processes to protect patient identities.
While Azra AI boasts >99% AI precision, it's crucial to remember that AI tools augment, rather than replace, a physician's diagnostic judgment and clinical understanding. Physicians must provide rigorous oversight and validate AI-generated outputs, as AI may not always grasp nuances like atypical presentations or rare conditions. The absence of an emotional bond in AI also highlights the irreplaceable role of human empathy in patient care.
Yes, there are other clinical AI and decision support tools available, such as UpToDate, AMBOSS, ClinicalKey AI, and various AI scribes like Abridge and Suki AI. Azra AI distinguishes itself as an enterprise platform that operationalizes underutilized data to optimize and orchestrate entire care and clinical trial pathways, focusing on closed-loop patient management from detection to completed care across multiple service lines.
Azra AI is an enterprise-level platform designed for health systems and hospitals, rather than individual practitioners. While specific pricing for Azra AI is not publicly disclosed, enterprise AI platforms with multi-system integration typically range from $300,000 to $500,000+. The cost depends on factors like use case, data readiness, and integration needs.
Suggest an Edit →
| Last Verified: 2026-09-09 | First Added: 2026-09-09